ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 255 filers reported holding ICU MED INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,177 | -32.4% | 951 | +1.2% | 0.00% | -50.0% |
| Q2 2023 | $167,500 | -4.3% | 940 | -11.4% | 0.00% | 0.0% |
| Q1 2023 | $175,023 | +8.4% | 1,061 | +3.5% | 0.00% | 0.0% |
| Q4 2022 | $161,416 | -10.8% | 1,025 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $181,000 | +4.0% | 1,205 | +14.1% | 0.00% | 0.0% |
| Q2 2022 | $174,000 | -4.9% | 1,056 | +28.8% | 0.00% | 0.0% |
| Q1 2022 | $183,000 | -1.1% | 820 | +5.1% | 0.00% | 0.0% |
| Q4 2021 | $185,000 | +2.2% | 780 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $181,000 | +23.1% | 776 | +8.7% | 0.00% | +100.0% |
| Q2 2021 | $147,000 | +54.7% | 714 | +54.9% | 0.00% | 0.0% |
| Q1 2021 | $95,000 | -4.0% | 461 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $99,000 | +17.9% | 461 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $84,000 | -1.2% | 461 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $85,000 | -11.5% | 461 | -2.7% | 0.00% | -50.0% |
| Q1 2020 | $96,000 | +5.5% | 474 | -2.3% | 0.00% | +100.0% |
| Q4 2019 | $91,000 | +2.2% | 485 | -13.2% | 0.00% | 0.0% |
| Q3 2019 | $89,000 | -25.2% | 559 | +17.9% | 0.00% | -50.0% |
| Q2 2019 | $119,000 | +21.4% | 474 | +15.3% | 0.00% | 0.0% |
| Q1 2019 | $98,000 | -3.9% | 411 | -7.2% | 0.00% | 0.0% |
| Q4 2018 | $102,000 | +3.0% | 443 | +26.6% | 0.00% | 0.0% |
| Q3 2018 | $99,000 | +2.1% | 350 | +6.1% | 0.00% | 0.0% |
| Q2 2018 | $97,000 | -13.4% | 330 | -25.8% | 0.00% | 0.0% |
| Q1 2018 | $112,000 | +13.1% | 445 | -3.1% | 0.00% | 0.0% |
| Q4 2017 | $99,000 | +16.5% | 459 | 0.0% | 0.00% | +100.0% |
| Q3 2017 | $85,000 | +7.6% | 459 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $79,000 | +12.9% | 459 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $70,000 | +2.9% | 459 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $68,000 | -24.4% | 459 | -35.4% | 0.00% | -50.0% |
| Q3 2016 | $90,000 | +210.3% | 710 | -14.6% | 0.00% | +100.0% |
| Q1 2010 | $29,000 | -6.5% | 831 | -2.4% | 0.00% | 0.0% |
| Q4 2009 | $31,000 | 0.0% | 851 | +1.2% | 0.00% | 0.0% |
| Q3 2009 | $31,000 | -20.5% | 841 | -10.1% | 0.00% | -50.0% |
| Q2 2009 | $39,000 | -27.8% | 936 | -44.2% | 0.00% | -33.3% |
| Q1 2009 | $54,000 | – | 1,676 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |